Table 4 Serum MU5AC positivity in each clinicopathologic parameters
From: Humoral immune response to MUC5AC in patients with colorectal polyps and colorectal carcinoma
| Â | MUC5AC Ab negative | MUC5AC Ab positive | Â | ||
|---|---|---|---|---|---|
| Â | N | (%) | N | (%) | Â |
Age | Â | Â | Â | Â | Â |
   ≤60 | (5) | 29.4 | (12) | 70.6 |  |
   >60 | (7) | 53.8 | (6) | 46.2 |  |
| Â | Â | Â | Â | Â | (p = 0.176) |
Sex | Â | Â | Â | Â | Â |
   Female | (8) | 66.7 | (4) | 33.3 |  |
   Male | (4) | 22.2 | (14) | 77.8 |  |
| Â | Â | Â | Â | Â | (p = 0.015) |
Tumor Location | Â | Â | Â | Â | Â |
   Colon | (8) | 33.3 | (16) | 66.7 |  |
   Rectum | (4) | 66.7 | (2) | 33.3 |  |
| Â | Â | Â | Â | Â | (p = 0.116) |
Duke's Stage | Â | Â | Â | Â | Â |
   B | (4) | 50.0 | (4) | 50.0 |  |
   C | (6) | 54.5 | (5) | 45.5 |  |
   D | (27) | 31.3 | (8) | 72.7 |  |
| Â | Â | Â | Â | Â | (p = 0.25) |
Histologic type | Â | Â | Â | Â | Â |
   Adeno Ca | (12) | 44.4 | (15) | 55.6 |  |
   Mucinous Ca | - | - | (1) | 100 |  |
   Adenosquamous Ca | - | - | (1) | 100 |  |
   Adenocarcinoid Ca | - | - | (1) | 100 |  |
| Â | Â | Â | Â | Â | (p = 0.528) |
Differentiation | Â | Â | Â | Â | Â |
   Well | (3) | 50.0 | (3) | 50.0 |  |
   Moderate | (9) | 47.4 | (10) | 52.6 |  |
   Poor | - | - | (4) | 100 |  |
   Mucinous | - | - | (1) | 100 |  |
| Â | Â | Â | Â | Â | (p = 0.260) |
Metastatic Lymph Node | Â | Â | Â | Â | Â |
   Absent | (3) | 37.5 | (5) | 62.5 |  |
   Present | (9) | 40.9 | (3) | 59.1 |  |
| Â | Â | Â | Â | Â | (p = 0.866) |
Preoperative Metastasis | Â | Â | Â | Â | Â |
   Absent | (9) | 47.4 | (10) | 52.6 |  |
   Present | (27) | 31.3 | (8) | 72.7 |  |
| Â | Â | Â | Â | Â | (p = 0.219) |